Department of Ophthalmology, New York Eye and Ear Infirmary at Mount Sinai, New York, NY, United States.
iMacular Regeneration, LLC, Rochester, MN, United States.
Asia Pac J Ophthalmol (Phila). 2024 Jan-Feb;13(1):100036. doi: 10.1016/j.apjo.2024.100036. Epub 2024 Jan 19.
Decades of studies on age-related macular degeneration (AMD), cardiovascular disease and stroke have not found consistent associations between AMD and systemic vascular disease. This study suggests that there is in fact no general relationship, but instead a strong, specific association between only the subretinal drusenoid deposit (SDD) phenotype of AMD on retinal imaging and certain co-existent vascular diseases that are high risk for compromised cardiac output or internal carotid artery stenosis. Future screening initiatives for these high -risk vascular diseases (HRVDs) with fast, inexpensive retinal imaging could make a significant contribution to public health and save lives. Likewise, screening patients with known HRVDs for unrecognized AMD of the SDD form could enable needed treatment and save vision.
数十年的年龄相关性黄斑变性(AMD)、心血管疾病和中风研究并未发现 AMD 与系统性血管疾病之间存在一致的关联。本研究表明,实际上两者之间没有普遍的关系,而是在视网膜成像上仅存在一种强烈的、特定的关联,即 AMD 的视网膜下类脂沉积(SDD)表型与某些并存的血管疾病有关,这些血管疾病存在心输出量降低或颈内动脉狭窄的高风险。未来可以利用快速、廉价的视网膜成像对这些高风险血管疾病(HRVDs)进行筛查,这将对公共健康做出重大贡献并挽救生命。同样,对已知患有 HRVD 的患者进行筛查,发现未知的 SDD 形式的 AMD,也可以进行必要的治疗并挽救视力。